Skip to Content

Drug Interactions between Azithromycin Dose Pack and MethylPREDNISolone Dose Pack

This report displays the potential drug interactions for the following 2 drugs:

  • Azithromycin Dose Pack (azithromycin)
  • MethylPREDNISolone Dose Pack (methylprednisolone)

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Azithromycin Dose Pack and MethylPREDNISolone Dose Pack. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Azithromycin Dose Pack

A total of 325 drugs are known to interact with Azithromycin Dose Pack.

MethylPREDNISolone Dose Pack

A total of 496 drugs are known to interact with MethylPREDNISolone Dose Pack.

Drug and food interactions


methylPREDNISolone food

Applies to: MethylPREDNISolone Dose Pack (methylprednisolone)

Grapefruit juice may increase the blood levels of certain medications such as methylPREDNISolone. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with methylPREDNISolone. However, if you have been regularly consuming grapefruit or grapefruit juice with the medication, then it is advisable for you to talk with your doctor before changing the amounts of these products in your diet, as this may alter the effects of your medication. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.